Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01021410 · ClinicalTrials.gov registry record
Acetaminophen-Protein Adduct Resolution
A clinical trial, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- 100
- Enrollment target
NCT01021410 is a clinical trial that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 100 participants.
The verdict
NCT01021410 has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the pharmacokinetics of acetaminophen and further clinical interpretations of laboratory results that confirm the presence of acetaminophen-cys adducts. This study will determine how long adducts persist in serum after a therapeutic course of acetaminophen as taken in a previous study (COMIRB 06-1265). Subjects will be asked to complete three study visits, each three days apart, following termination of COMIRB 06-1265. Each study visit will include collection of blood samples for batch testing of aminotransferase, serum acetaminophen and protein adducts. No interventions are planned.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01021410
The ClinicalTrials.gov registry entry for NCT01021410 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Denver Health and Hospital Authority, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01021410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01021410 about?
NCT01021410 is a clinical study titled "Acetaminophen-Protein Adduct Resolution". The purpose of this study is to better understand the pharmacokinetics of acetaminophen and further clinical interpretations of laboratory results that confirm the presence of acetaminophen-cys adducts. This study will determine how long adducts persist in serum after a therapeutic course of acetami...
What is the current status of trial NCT01021410?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-11. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT01021410?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.